Compare LEGN & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEGN | VIRT |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.0B |
| IPO Year | 2020 | 2014 |
| Metric | LEGN | VIRT |
|---|---|---|
| Price | $17.42 | $59.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | $42.46 | ★ $70.29 |
| AVG Volume (30 Days) | ★ 2.3M | 1.0M |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.61% |
| EPS Growth | N/A | ★ 72.73 |
| EPS | N/A | ★ 5.27 |
| Revenue | N/A | ★ $3,632,118,000.00 |
| Revenue This Year | $38.71 | $2.76 |
| Revenue Next Year | $18.83 | N/A |
| P/E Ratio | ★ N/A | $11.30 |
| Revenue Growth | N/A | ★ 26.25 |
| 52 Week Low | $16.24 | $31.55 |
| 52 Week High | $37.50 | $68.76 |
| Indicator | LEGN | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 63.65 |
| Support Level | $17.43 | $53.22 |
| Resistance Level | $19.92 | $60.97 |
| Average True Range (ATR) | 1.50 | 2.14 |
| MACD | -0.47 | 0.73 |
| Stochastic Oscillator | 1.15 | 87.38 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.